The present data showed that the expression level of FOXP3 increased significantly with tumor grade, while there was no significant association of the PB levels of PDL-1, CTLA-4, and PD-1 and the other clinic-pathological features of the BC patients. This evidence concerns the gene PDCD1 and breast cancer.